Contact laser vaporization of the prostate for benign prostatic hypertrophy

The contact laser applications for the removal of the enlarged prostate are distinctly different than the majority of non-contact Nd:YAG lasers that rely on coagulation necrosis and delayed sloughing. Contact Nd:YAG laser allows cutting, coagulation and vaporization of tissue with minimal penetration beyond the contact surface. Using the contact laser prostatectomy technique, the contact laser probe directly touches and immediately vaporizes the prostatic tissue under the probe. The net result is the immediate removal of the obstructing tissue, in a manner similar to the standard electrosurgical TURP. This immediate removal of tissue offers the patient treated with the contact laser the potential for decreased catheter time and a more rapid resolution of symptoms. Our initial experience suggests that the contact technique may be better suited for the smaller prostate gland (i.e. less than 30 gm). The contact laser may also be used for a procedure termed the `laser assisted TURP': a standard electrosurgical TURP is performed and the contact laser is used for hemostasis. Several investigators have reported non-randomized results of the contact technique with good outcomes. A prospective randomized trial of the contact laser prostatectomy vrs the electrosurgical TURP is underway. The contact laser vaporization of the prostate holds great promise for the treatment of symptomatic benign prostatic hypertrophy: it is virtually bloodless and allows immediate visualization of the TUR defect.

[1]  A T Cockett,et al.  Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. , 1989, The Journal of urology.

[2]  R K Babayan,et al.  Transurethral ultrasound-guided laser-induced prostatectomy: National Human Cooperative Study results. , 1993, The Journal of urology.

[3]  J P Norris,et al.  Visual laser ablation of the prostate: clinical experience in 108 patients. , 1993, The Journal of urology.

[4]  C. Chapple,et al.  The UroLume stent in the management of benign prostatic hyperplasia. , 1993, The Journal of urology.

[5]  R J Glynn,et al.  The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. , 1985, American journal of epidemiology.

[6]  J. Kabalin,et al.  Laser prostatectomy performed with a right-angle firing neodymium:YAG laser fiber at 60 watts power setting. , 1995, The Journal of urology.

[7]  Douglas E. Johnson,et al.  Laser photoirradiation of the canine ureteral orifice: Comparison between contact and noncontact techniques , 1989, Lasers in surgery and medicine.

[8]  A. Costello,et al.  Laser ablation of the prostate in patients with benign prostatic hypertrophy. , 1992, British journal of urology.

[9]  R. Price,et al.  Pathologic changes occurring in the prostate following transurethral laser prostatectomy , 1992, Lasers in surgery and medicine.

[10]  E. J. Mueller Contact laser vaporization of the prostate , 1996 .

[11]  E. Crawford,et al.  Randomized clinical trial comparing balloon dilatation to transurethral resection of prostate for benign prostatic hyperplasia. , 1993, Urology.